82 related articles for article (PubMed ID: 20440755)
1. Functional HIV-2- and SIVsmmPBj- derived lentiviral vectors generated by a novel polymerase chain reaction-based approach.
Kloke BP; Schüle S; Mühlebach MD; Wolfrum N; Cichutek K; Schweizer M
J Gene Med; 2010 May; 12(5):446-52. PubMed ID: 20440755
[TBL] [Abstract][Full Text] [Related]
2. Stable transduction of primary human monocytes by simian lentiviral vector PBj.
Mühlebach MD; Wolfrum N; Schüle S; Tschulena U; Sanzenbacher R; Flory E; Cichutek K; Schweizer M
Mol Ther; 2005 Dec; 12(6):1206-16. PubMed ID: 16150648
[TBL] [Abstract][Full Text] [Related]
3. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.
Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K
Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888
[TBL] [Abstract][Full Text] [Related]
4. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
5. Novel bovine lentiviral vectors based on Jembrana disease virus.
Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
[TBL] [Abstract][Full Text] [Related]
6. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.
Nègre D; Mangeot PE; Duisit G; Blanchard S; Vidalain PO; Leissner P; Winter AJ; Rabourdin-Combe C; Mehtali M; Moullier P; Darlix JL; Cosset FL
Gene Ther; 2000 Oct; 7(19):1613-23. PubMed ID: 11083469
[TBL] [Abstract][Full Text] [Related]
7. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K
J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
9. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
[TBL] [Abstract][Full Text] [Related]
11. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Kuate S; Wagner R; Uberla K
J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex.
Shimizu S; Urano E; Futahashi Y; Miyauchi K; Isogai M; Matsuda Z; Nohtomi K; Onogi T; Takebe Y; Yamamoto N; Komano J
AIDS; 2007 Mar; 21(5):575-82. PubMed ID: 17314519
[TBL] [Abstract][Full Text] [Related]
14. Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells.
Böcker W; Rossmann O; Docheva D; Malterer G; Mutschler W; Schieker M
J Gene Med; 2007 Jul; 9(7):585-95. PubMed ID: 17510916
[TBL] [Abstract][Full Text] [Related]
15. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
17. A lentiviral vector with novel multiple cloning sites: stable transgene expression in vitro and in vivo.
Santhosh CV; Tamhane MC; Kamat RH; Patel VV; Mukhopadhyaya R
Biochem Biophys Res Commun; 2008 Jul; 371(3):546-50. PubMed ID: 18448070
[TBL] [Abstract][Full Text] [Related]
18. A HIV-2-based self-inactivating vector for enhanced gene transduction.
Mukherjee S; Lee HL; Pacchia AL; Ron Y; Dougherty JP
J Biotechnol; 2007 Jan; 127(4):745-57. PubMed ID: 16979253
[TBL] [Abstract][Full Text] [Related]
19. Multiple platforms of a HIV-2 derived lentiviral vector for expanded utility.
Chande AG; Raina S; Dhamne H; Kamat RH; Mukhopadhyaya R
Plasmid; 2013 Jan; 69(1):90-5. PubMed ID: 23159456
[TBL] [Abstract][Full Text] [Related]
20. Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cells.
Wolfrum N; Mühlebach MD; Schüle S; Kaiser JK; Kloke BP; Cichutek K; Schweizer M
Virology; 2007 Aug; 364(2):330-41. PubMed ID: 17418360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
